Cargando…

mRNA Innovates the Vaccine Field

Detalles Bibliográficos
Autor principal:	Pardi, Norbert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151794/ https://www.ncbi.nlm.nih.gov/pubmed/34064557 http://dx.doi.org/10.3390/vaccines9050486

Ejemplares similares

Innate immune mechanisms of mRNA vaccines
por: Verbeke, Rein, et al.
Publicado: (2022)

Recent Updates on mRNA Vaccines
por: Sydow, Emily, et al.
Publicado: (2022)

mRNA Covid-19 Vaccines in Pregnant Women
por: Riley, Laura E.
Publicado: (2021)

Approved mRNA Vaccines for SARS-CoV-2
por: Faiman, Beth
Publicado: (2021)

Receipt of mRNA Vaccine against Covid-19 and Myocarditis
por: Caforio, Alida L.P.
Publicado: (2021)

Coronavirus disease 2019 and mRNA vaccines: what’s next – miRNA?
por: Lee, Joon Kee, et al.
Publicado: (2022)

mRNA-1273 but not BNT162b2 induces antibodies against polyethylene glycol (PEG) contained in mRNA-based vaccine formulations
por: Carreño, Juan Manuel, et al.
Publicado: (2022)

Lyophilization provides long-term stability for a lipid nanoparticle-formulated, nucleoside-modified mRNA vaccine
por: Muramatsu, Hiromi, et al.
Publicado: (2022)

Effect of mRNA-LNP components of two globally-marketed COVID-19 vaccines on efficacy and stability
por: Zhang, Lizhou, et al.
Publicado: (2023)

Antigen modifications improve nucleoside-modified mRNA-based influenza virus vaccines in mice
por: Freyn, Alec W., et al.
Publicado: (2021)

mRNA Metabolism in Health and Disease
por: Romão, Luísa
Publicado: (2022)

One Year of COVID-19 mRNA Vaccines: Incredible Progress and Unfinished Business
por: Jhaveri, Ravi
Publicado: (2021)

Covid-19 mRNA Vaccines — Six of One, Half a Dozen of the Other
por: Rubin, Eric J., et al.
Publicado: (2021)

Editorial: mRNA Vaccines and Future Epidemic, Pandemic, and Endemic Zoonotic Virus Infections
por: Parums, Dinah V.
Publicado: (2021)

Editorial: mRNA Vaccines and Immunotherapy in Oncology: A New Era for Personalized Medicine
por: Parums, Dinah V.
Publicado: (2021)

mRNA as a Therapeutics: Understanding mRNA Vaccines
por: Oğuz, Ferdi, et al.
Publicado: (2022)

mRNA Vaccine Platform: mRNA Production and Delivery
por: Litvinova, V. R., et al.
Publicado: (2023)

Chimeric spike mRNA vaccines protect against Sarbecovirus challenge in mice
por: Martinez, David R., et al.
Publicado: (2021)

Chimeric spike mRNA vaccines protect against Sarbecovirus challenge in mice
por: Martinez, David R., et al.
Publicado: (2021)

A 4D view on mRNA
por: Smith, Carlas, et al.
Publicado: (2015)

Cardiovascular disease, inflammation, and mRNA stability
por: Herman, Allison B., et al.
Publicado: (2018)

Dangers of mRNA vaccines
por: Ali, Tahoora, et al.
Publicado: (2021)

mRNA-Based Vaccines
por: Kowalzik, Frank, et al.
Publicado: (2021)

Advances in mRNA vaccines
por: Li, Mengyun, et al.
Publicado: (2022)

Suggested risk factor for oral lichen planus arising after mRNA COVID‐19 vaccination
por: Zargaran, Massoumeh
Publicado: (2022)

Remarks on Myocarditis Associated with COVID-19 Infection and Myocarditis Following mRNA COVID-19 Vaccination
por: Frustaci, Andrea
Publicado: (2022)

Characterization of HIV-1 Nucleoside-Modified mRNA Vaccines in Rabbits and Rhesus Macaques
por: Pardi, Norbert, et al.
Publicado: (2019)

Editorial: SARS-CoV-2 mRNA Vaccines and the Possible Mechanism of Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT)
por: Parums, Dinah V.
Publicado: (2021)

mRNA vaccines: the most recent clinical applications of synthetic mRNA
por: Kwon, Suji, et al.
Publicado: (2022)

Myocarditis following COVID‐19 mRNA (mRNA‐1273) vaccination
por: Chellapandian, Suresh Babu, et al.
Publicado: (2022)

Nucleoside-Modified mRNA Vaccines Protect IFNAR(–/–) Mice against Crimean-Congo Hemorrhagic Fever Virus Infection
por: Appelberg, Sofia, et al.
Publicado: (2022)

Development of a pentavalent broadly protective nucleoside-modified mRNA vaccine against influenza B viruses
por: Pardi, Norbert, et al.
Publicado: (2022)

HIV and Messenger RNA (mRNA) Vaccine
por: Khalid, Khizer, et al.
Publicado: (2021)

RNA modification in mRNA cancer vaccines
por: Mei, Yingxue, et al.
Publicado: (2023)

Protection against herpes simplex virus type 2 infection in a neonatal murine model using a trivalent nucleoside-modified mRNA in lipid nanoparticle vaccine
por: LaTourette, Philip C., et al.
Publicado: (2020)

Critical aspects of packaging, storage, preparation, and administration of mRNA and adenovirus-vectored COVID-19 vaccines for optimal efficacy
por: Holm, Michelle R., et al.
Publicado: (2021)

Variant constraint by mRNA vaccines
por: Bordon, Yvonne
Publicado: (2021)

COVID-19 mRNA vaccines
por: Huang, Qingrui, et al.
Publicado: (2021)

mRNA Vaccines against Flaviviruses
por: Wollner, Clayton J., et al.
Publicado: (2021)

mRNA vaccine for cancer immunotherapy
por: Miao, Lei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tmqs8ca3jt44ma8bbmt69df3in